Cargando…
Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
Mitophagy is a conserved cellular process that plays a vital role in maintaining cellular homeostasis by selectively removing dysfunctional mitochondria. Notwithstanding that growing evidence suggests that mitophagy is implicated in pancreatic tumorigenesis, the effect of mitophagy-related genes on...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860183/ https://www.ncbi.nlm.nih.gov/pubmed/35198564 http://dx.doi.org/10.3389/fcell.2021.802528 |
_version_ | 1784654614529835008 |
---|---|
author | Zhuo, Zewei Lin, Hanying Liang, Jun Ma, Pengyue Li, Jingwei Huang, Lin Chen, Lishan Yang, Hongwei Bai, Yang Sha, Weihong |
author_facet | Zhuo, Zewei Lin, Hanying Liang, Jun Ma, Pengyue Li, Jingwei Huang, Lin Chen, Lishan Yang, Hongwei Bai, Yang Sha, Weihong |
author_sort | Zhuo, Zewei |
collection | PubMed |
description | Mitophagy is a conserved cellular process that plays a vital role in maintaining cellular homeostasis by selectively removing dysfunctional mitochondria. Notwithstanding that growing evidence suggests that mitophagy is implicated in pancreatic tumorigenesis, the effect of mitophagy-related genes on pancreatic cancer (PC) prognosis and therapeutic response remains largely unknown. In this study, we sought to construct a mitophagy-related gene signature and assessed its ability to predict the survival, immune activity, mutation status, and chemotherapy response of PC patients. During the screening process, we identified three mitophagy-related genes (PRKN, SRC, VDAC1) from The Cancer Genome Atlas (TCGA) cohort and a 3-gene signature was established. The prognostic model was validated using an International Cancer Genome Consortium (ICGC) cohort and two Gene Expression Omnibus (GEO) cohorts. According to the median risk score, PC patients were divided into high and low-risk groups, and the high-risk group correlated with worse survival in the four cohorts. The risk score was then identified as an independent prognostic predictor, and a predictive nomogram was constructed to guide clinical decision-making. Remarkably, enhanced immunosuppressive levels and higher mutation rates were observed in patients from the high-risk group, which may account for their poor survival. Furthermore, we found that high-risk patients were more sensitive to paclitaxel and erlotinib. In conclusion, a mitophagy-related gene signature is a novel prognostic model that can be used as a predictive indicator and allows prognostic stratification of PC patients. |
format | Online Article Text |
id | pubmed-8860183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88601832022-02-22 Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer Zhuo, Zewei Lin, Hanying Liang, Jun Ma, Pengyue Li, Jingwei Huang, Lin Chen, Lishan Yang, Hongwei Bai, Yang Sha, Weihong Front Cell Dev Biol Cell and Developmental Biology Mitophagy is a conserved cellular process that plays a vital role in maintaining cellular homeostasis by selectively removing dysfunctional mitochondria. Notwithstanding that growing evidence suggests that mitophagy is implicated in pancreatic tumorigenesis, the effect of mitophagy-related genes on pancreatic cancer (PC) prognosis and therapeutic response remains largely unknown. In this study, we sought to construct a mitophagy-related gene signature and assessed its ability to predict the survival, immune activity, mutation status, and chemotherapy response of PC patients. During the screening process, we identified three mitophagy-related genes (PRKN, SRC, VDAC1) from The Cancer Genome Atlas (TCGA) cohort and a 3-gene signature was established. The prognostic model was validated using an International Cancer Genome Consortium (ICGC) cohort and two Gene Expression Omnibus (GEO) cohorts. According to the median risk score, PC patients were divided into high and low-risk groups, and the high-risk group correlated with worse survival in the four cohorts. The risk score was then identified as an independent prognostic predictor, and a predictive nomogram was constructed to guide clinical decision-making. Remarkably, enhanced immunosuppressive levels and higher mutation rates were observed in patients from the high-risk group, which may account for their poor survival. Furthermore, we found that high-risk patients were more sensitive to paclitaxel and erlotinib. In conclusion, a mitophagy-related gene signature is a novel prognostic model that can be used as a predictive indicator and allows prognostic stratification of PC patients. Frontiers Media S.A. 2022-02-07 /pmc/articles/PMC8860183/ /pubmed/35198564 http://dx.doi.org/10.3389/fcell.2021.802528 Text en Copyright © 2022 Zhuo, Lin, Liang, Ma, Li, Huang, Chen, Yang, Bai and Sha. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Zhuo, Zewei Lin, Hanying Liang, Jun Ma, Pengyue Li, Jingwei Huang, Lin Chen, Lishan Yang, Hongwei Bai, Yang Sha, Weihong Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title | Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title_full | Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title_fullStr | Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title_full_unstemmed | Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title_short | Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer |
title_sort | mitophagy-related gene signature for prediction prognosis, immune scenery, mutation, and chemotherapy response in pancreatic cancer |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860183/ https://www.ncbi.nlm.nih.gov/pubmed/35198564 http://dx.doi.org/10.3389/fcell.2021.802528 |
work_keys_str_mv | AT zhuozewei mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT linhanying mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT liangjun mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT mapengyue mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT lijingwei mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT huanglin mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT chenlishan mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT yanghongwei mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT baiyang mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer AT shaweihong mitophagyrelatedgenesignatureforpredictionprognosisimmunescenerymutationandchemotherapyresponseinpancreaticcancer |